-
EP3836920
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3836920
| EP3836920 - FORMULATIONS OF AG10 [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 21.07.2023 Database last updated on 12.11.2024 | |
| Former | Request for examination was made Status updated on 21.05.2021 | ||
| Former | The international publication has been made Status updated on 24.02.2020 | Most recent event Tooltip | 05.07.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Eidos Therapeutics, Inc. 101 Montgomery Street 25th Floor San Francisco, CA 94104 / US | [2021/25] | Inventor(s) | 01 /
JERNELIUS, Jesper 101 Montgomery Street 25th Floor San Francisco, California 94104 / US | 02 /
MENNING, Mark Michael 101 Montgomery Street 25th Floor San Francisco, California 94104 / US | [2021/25] | Representative(s) | J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | [N/P] |
| Former [2021/25] | J A Kemp LLP 14 South Square Gray's Inn London WC1R 5JJ / GB | Application number, filing date | 19849948.5 | 16.08.2019 | [2021/25] | WO2019US46789 | Priority number, date | US201862765154P | 17.08.2018 Original published format: US 201862765154 P | [2021/25] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020037189 | Date: | 20.02.2020 | Language: | EN | [2020/08] | Type: | A1 Application with search report | No.: | EP3836920 | Date: | 23.06.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 20.02.2020 takes the place of the publication of the European patent application. | [2021/25] | Search report(s) | International search report - published on: | US | 20.02.2020 | (Supplementary) European search report - dispatched on: | EP | 15.03.2022 | Classification | IPC: | A61K31/415, A61K9/20 | [2022/15] | CPC: |
A61K31/415 (EP,IL,KR,US);
A61K9/2054 (EP,IL,KR,US);
A61K9/2009 (IL,US);
A61K9/2833 (IL,KR,US)
|
| Former IPC [2021/25] | A61K31/415, A61K9/20, A61K47/02 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/25] | Extension states | BA | 10.03.2021 | ME | 10.03.2021 | Validation states | KH | 10.03.2021 | MA | 10.03.2021 | MD | 10.03.2021 | TN | 10.03.2021 | Title | German: | AG10-FORMULIERUNGEN | [2021/25] | English: | FORMULATIONS OF AG10 | [2021/25] | French: | FORMULES D'AG10 | [2021/25] | Entry into regional phase | 10.03.2021 | National basic fee paid | 10.03.2021 | Search fee paid | 10.03.2021 | Designation fee(s) paid | 10.03.2021 | Examination fee paid | Examination procedure | 10.03.2021 | Examination requested [2021/25] | 07.10.2022 | Amendment by applicant (claims and/or description) | 25.07.2023 | Despatch of a communication from the examining division (Time limit: M04) | 27.11.2023 | Reply to a communication from the examining division | Fees paid | Renewal fee | 13.08.2021 | Renewal fee patent year 03 | 18.07.2022 | Renewal fee patent year 04 | 05.07.2023 | Renewal fee patent year 05 | 04.07.2024 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]US2013095181 (VERWIJS MARINUS JACOBUS [US], et al); | [Y]WO2018071678 (GLOBAL BLOOD THERAPEUTICS INC [US]) | International search | [X]US9913826 (GRAEF ISABELLA A [US], et al) | by applicant | US2013095181 | WO2014100227 | US9913826 | WO2018071678 |